Newsfile Corp
02 Jun 2026, 03:08 UTC · 2h ago
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA
Newsfile Corp
02 Jun 2026, 03:08 UTC · 2h ago
Story key points
2 claims · impact-rated
Culper Research alleged that ADMA Biologics engaged in channel stuffing to inflate revenue growth. — Allegations of revenue inflation through channel stuffing suggest fundamental accounting irregularities and often lead to severe valuation corrections.
-0.80The Rosen Law Firm is investigating potential securities claims and preparing a class action lawsuit against ADMA Biologics. — Formal legal action following short-seller allegations increases the likelihood of regulatory scrutiny and potential financial settlements.
-0.40Ticker attribution
Model heads
The company is facing a securities class action investigation following allegations of channel stuffing to inflate revenue.
Continue reading
6 related stories
Search tags
The company is mentioned in the context of an ongoing securities class action lawsuit.
The company is mentioned in the context of an ongoing securities class action lawsuit.
The company is mentioned in the context of an ongoing securities class action lawsuit.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
7 dimensions · 9 clusters
Market reaction
0 bid · 10 offered
No stock impact ranking available yet.
Newsfile Corp
2h ago
